ArticleQuantitative imaging in medicine and surgery2025
Diabetic retinal vessel segmentation algorithm based on MA-DUNet.
Article in Quantitative imaging in medicine and surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Precise retinal vessel segmentation is crucial for the diagnosis of ocular diseases. This meticulous process can promptly capture retinal vessel abnormalities, which in turn can facilitate early diagnosis and timely treatment. However, retinal vessels exhibit complex branching patterns with different diameters and contrasts, making it difficult to segment tiny vessels and low-contrast areas, and identify subtle terminal branches. This study aimed to improve the accuracy of retinal vessel segmentation and ultimately improve the efficiency of clinical diagnosis. Methods: In this study, we proposed the Multi-modal Attention Deformable U-shaped Network (MA-DUNet) to enhance retinal vessel segmentation performance. This model was designed to enhance segmentation accuracy through three key strategies. First, it incorporates atrous multi-scale (AMS) convolutions in the encoding stage to enhance the perception of information across different scales, thereby improving the extraction and representation of image features. Second, a gated channel transformation (GCT) attention mechanism is introduced between the encoder and decoder to improve feature transmission and extract crucial information. This mechanism dynamically adjusts the relationships among feature channels, emphasizing important task-related features while suppressing irrelevant ones. Third, a Multi-Modal Attention Fusion Block (MAFB), which combines the Multi-Modal Fusion Block (MFB) and GCT attention mechanism, is used during the decoding process to optimize information usage and enhance segmentation performance. Results: Images from three public datasets [i.e., digital retinal images for vessel extraction (DRIVE), structured analysis of the retina (STARE), and Child Heart and Health Study in England Database 1 (CHASE-DB1)] were analyzed. In terms of blood vessel segmentation, the model had accuracy values of 95.72%, 96.68%, and 96.38%, and area under the receiver operating characteristic (ROC) curve values of 98.10%, 98.89%, and 98.35% for the three datasets, respectively. Additionally, when validated using data from hospital collaborations, our model outperformed other comparative models in terms of the segmentation results. Conclusions: Our proposed MA-DUNet model provides more accurate segmentation of the fine terminal branches of vessels, effectively eliminating blurred boundaries and fragmentation in the segmentation outcomes, resulting in clearer vascular segmentation results.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.